[HTML][HTML] SULF1 作为特发性肺纤维化与肺腺癌共同基因的鉴定及其生物学功能分析
W Junyi, LU Lu, HE Xiang, MA Lijuan… - Chinese Journal of …, 2023 - ncbi.nlm.nih.gov
背景和目的特发性肺纤维化（ idiopathic pulmonary fibrosis, IPF） 是一种原因不明的慢性、
进行性、 间质性肺疾病， 确诊后中位生存期为3-5 年。 IPF 与肺癌风险增加有关。 因此， 探索IPF …
进行性、 间质性肺疾病， 确诊后中位生存期为3-5 年。 IPF 与肺癌风险增加有关。 因此， 探索IPF …
Identification of SULF1 as a Shared Gene in Idiopathic Pulmonary Fibrosis and Lung Adenocarcinoma.
W Junyi, LU Lu, HE Xiang, MA Lijuan… - Chinese Journal of …, 2023 - search.ebscohost.com
Background and objective Idiopathic pulmonary fibrosis (IPF) is an idiopathic chronic,
progressive interstitial lung disease with a diagnosed median survival of 3-5 years. IPF is …
progressive interstitial lung disease with a diagnosed median survival of 3-5 years. IPF is …
[HTML][HTML] Exploration of the shared genes and signaling pathways between lung adenocarcinoma and idiopathic pulmonary fibrosis
H Li, W Wang, Z Huang, P Zhang, L Liu… - Journal of Thoracic …, 2023 - ncbi.nlm.nih.gov
Background Idiopathic pulmonary fibrosis (IPF), a type of interstitial lung disease (ILD), is a
chronic disease with an unknown etiology. The occurrence of lung cancer (LC) is one of the …
chronic disease with an unknown etiology. The occurrence of lung cancer (LC) is one of the …
[HTML][HTML] 特发性肺纤维化合并非小细胞肺癌的致病机制及潜在治疗药物研究进展
肖婷， 暴嘉丽， 刘湘宁， 黄慧， 周红刚 - Chinese Journal of Lung …, 2022 - ncbi.nlm.nih.gov
特发性肺纤维化（ idiopathic pulmonary fibrosis, IPF） 是病因不明的慢性进行性纤维化性间质性
肺疾病， IPF 也被认为是肺癌的独立风险因素之一， 可增加7%-20% 的LC 发病风险。 IPF …
肺疾病， IPF 也被认为是肺癌的独立风险因素之一， 可增加7%-20% 的LC 发病风险。 IPF …
[HTML][HTML] 特发性肺纤维化相关的肺癌发病机制的研究进展
卢蔷薇， 韩闪， 刘晓秋 - Chinese Journal of Lung Cancer, 2022 - ncbi.nlm.nih.gov
特发性肺纤维化（ idiopathic pulmonary fibrosis, IPF） 是一种原因不明的最常见的间质性肺疾病
（ interstitial lung disease, ILD）， 以最终导致肺间质纤维化为特征， 确诊后的中位生存期为2 年 …
（ interstitial lung disease, ILD）， 以最终导致肺间质纤维化为特征， 确诊后的中位生存期为2 年 …
SULF2 expression is a potential diagnostic and prognostic marker in lung cancer
NS Lui, YW Yang, A van Zante, P Buchanan… - PloS one, 2016 - journals.plos.org
Aims Lung cancer is one of the most deadly cancers; median survival from diagnosis is less
than one year in those with advanced disease. Novel lung cancer biomarkers are …
than one year in those with advanced disease. Novel lung cancer biomarkers are …
Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling
D Leng, J Yi, M Xiang, H Zhao, Y Zhang - BMC cancer, 2020 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is associated with an increased risk for lung
cancer, but the underlying mechanisms driving malignant transformation remain largely …
cancer, but the underlying mechanisms driving malignant transformation remain largely …
Research Progress on the Pathogenesis of Lung Cancer Associated with Idiopathic Pulmonary Fibrosis
LU Qiangwei, HAN Shan… - Zhongguo Fei Ai Za Zhi, 2022 - search.proquest.com
特发性肺纤维化 (idiopathic pulmonary fibrosis, IPF) 是一种原因不明的最常见的间质性肺疾病
(interstitial lung disease, ILD), 以最终导致肺间质纤维化为特征, 确诊后的中位生存期为 2 年-4 …
(interstitial lung disease, ILD), 以最终导致肺间质纤维化为特征, 确诊后的中位生存期为 2 年-4 …
特发性肺纤维化相关基因的筛选和生物信息学分析
邢静， 黄鑫炎， 郭禹标 - 中山大学学报: 医学科学版, 2017 - cqvip.com
[目的] 通过生物信息学的方法发现特发性肺纤维化(IPF) 的致病基因并为进一步研究提供靶点.[
方法] 从GEO 数据库中下载基因芯片数据集GSE53845, GSE24206, GSE10667 …
方法] 从GEO 数据库中下载基因芯片数据集GSE53845, GSE24206, GSE10667 …
Exploring key genes and mechanisms associated with idiopathic pulmonary fibrosis and lung adenocarcinoma
S Huang, X Wu, Y Sun, Z Xu, X Zhang - 2023 - researchsquare.com
Background: As the number of studies investigating idiopathic pulmonary fibrosis (IPF) and
lung adenocarcinoma (LUAD) continues to grow, increasing evidence supports a strong …
lung adenocarcinoma (LUAD) continues to grow, increasing evidence supports a strong …